Evolet Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Bhorakalan, Haryana, India, established in 2005.
2005 Bhorakalan, Haryana, India Active
Last Updated:
Access Report
About Evolet Pharmaceuticals Private Limited

Evolet Pharmaceuticals Private Limited, a active private limited company, was established on 06 April 2005 in Bhorakalan, Haryana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230HR2005PTC127251. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹28.00 Cr and a paid-up capital of ₹27.74 Cr.

Formerly known as Evolet Pharmaceuticals Private Limited, Anchal Lifescience Private Limited. It upholds a compliant status. Employing 82 professional, Its leadership includes Safarali Safarov (Director), Jamshed Mirzoev (Director), Akobir Zohidov (Director). Past directors included Khayrullo Avgonov, Shahnazar, Hiten Rasiklal Shah. It holds ₹2.00 Cr open charges and ₹8.40 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Unit No.1101, 11Th Floor Imperia Mindspace,, Golf Course Ext. Road Sec.62, Maidawas, Bhorakalan, Haryana, 122413.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230HR2005PTC127251

  • Registration Number

    127251

  • Incorporation Date

    06 April 2005

  • Authorized Capital

    ₹28.00 Cr

  • Paid-Up Capital

    ₹27.74 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 28.00 Cr
  • Paid Up Capital ₹ 27.74 Cr
  • Company Age 21 Year, 1 Month
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 2.00 Cr
  • Satisfied Charges ₹ 8.40 Cr
  • Revenue Growth **** -17.49%
  • Profit Growth **** -154.96%
  • Ebitda **** -826.34%
  • Net Worth 20.92%
  • Total Assets **** 4.62%
Company report

Evolet Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Evolet Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Evolet Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Safarali Safarov Director 18 Feb 2022 Current
Jamshed Mirzoev Director 08 May 2019 Current
Akobir Zohidov Director 04 Nov 2016 Current
Ilkhomzhon Mirzoev Director 27 Jul 2021 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Nov 2021 Past
Pramod Abcsdd Director 16 Sep 2021 Past
Pramod Abcsdd Director 25 Mar 2017 Past
Pramod Abcsdd Additional Director 30 Sep 2022 Past
Pramod Abcsdd Additional Director 25 Sep 2017 Past
Pramod Abcsdd Additional Director 28 Sep 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Evolet Pharmaceuticals.

Evolet Pharmaceuticals Private Limited, for the financial year ended 2024, experienced significant reduction in revenue, with a 17.49% decrease. The company also saw a substantial fall in profitability, with a 154.96% decrease in profit. The company's net worth Soared by an impressive increase of 20.92%.

Evolet Pharmaceuticals revenue growth over time
Evolet Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -17.49%
*******
*******
*******
*******
Revenue from Operations
*******
 -19.97%
*******
*******
*******
*******
Total Assets
*******
 4.62%
*******
*******
*******
*******
Profit or Loss
*******
 -154.96%
*******
*******
*******
*******
Net Worth
*******
 20.92%
*******
*******
*******
*******
EBITDA
*******
 -826.34%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Evolet Pharmaceuticals?

In 2024, Evolet Pharmaceuticals had a promoter holding of 29.65% and a public holding of 70.35%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹20,000,000.00

Satisfied Charges

₹84,000,000.00

Charges Breakdown by Lending Institutions
  • Others : 2.00 Cr
Latest Charge Details
Date Lender Amount Status
22 Jan 2018 Others ₹2.00 Cr Open
01 Mar 2013 Axis Bank Ltd. ₹1.00 M Satisfied
07 Dec 2012 Axis Bank Limited ₹1.90 Cr Satisfied
24 Nov 2012 Axis Bank Limited ₹1.50 Cr Satisfied
19 Jun 2006 State Bank Of India ₹2.45 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Evolet Pharmaceuticals?

Evolet Pharmaceuticals has a workforce of 82 employees as of Mar 06, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Evolet Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Evolet Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Evolet Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Evolet Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Evolet Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.

  • Director Appointment

    Safarali Safarov was appointed as a Director was appointed as a Director on 18 Feb 2022 & has been associated with this company since 4 years 3 months . was recorded as a recent event.

  • Director Appointment

    The activity Ilkhomzhon Mirzoev was appointed as a Director was appointed as a Director on 27 Jul 2021 & has been associated with this company since 4 years 9 months . was completed.

  • Director Appointment

    Vijay Pratap Singh Gautam was appointed as a Company Secretary was appointed as a Company Secretary on 25 Mar 2021 & has been associated with this company since 5 years 1 month . was recorded as a recent event.

  • Director Appointment

    Progress on Jamshed Mirzoev was appointed as a Director was appointed as a Director on 08 May 2019 & has been associated with this company since 7 years 14 days . was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Evolet Pharmaceuticals Private Limited?

The CIN of Evolet Pharmaceuticals Private Limited is U24230HR2005PTC127251.

Where is Evolet Pharmaceuticals Private Limited headquartered?

Evolet Pharmaceuticals Private Limited is headquartered at Unit No.1101, 11Th Floor Imperia Mindspace,, Golf Course Ext. Road Sec.62, Maidawas, Bhorakalan, Haryana, 122413.

When was Evolet Pharmaceuticals Private Limited incorporated?

Evolet Pharmaceuticals Private Limited was incorporated on 06 April 2005.

Who are the current directors of Evolet Pharmaceuticals Private Limited?

The current directors of Evolet Pharmaceuticals Private Limited are

What is the primary industry of Evolet Pharmaceuticals Private Limited?

The primary industry of Evolet Pharmaceuticals Private Limited is Manufacturing.

Is Evolet Pharmaceuticals Private Limited a listed company?

Evolet Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Evolet Pharmaceuticals Private Limited?

The authorized capital of Evolet Pharmaceuticals Private Limited is ₹28.00 Cr, and the paid-up capital is ₹27.74 Cr.

What is the compliance status of Evolet Pharmaceuticals Private Limited?

The compliance status of Evolet Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available